Vantage BioTrials to Present at the 10th Operational Excellence in Clinical Trials Summit
Join Vatché Bartekian for a Featured Presentation on Quality-by-Design and Risk-Based Governance
September 23–24, 2026 | Courtyard Toronto Downtown | Toronto, Canada
Vantage BioTrials is pleased to announce that Vatché Bartekian, President, has been invited to speak at the 10th Operational Excellence in Clinical Trials Summit (OECT Summit Canada 2026), one of Canada’s leading conferences dedicated to advancing innovation and operational excellence in clinical research. The summit brings together leaders in Clinical Operations, Clinical Development, Project Management, Study Feasibility, Site Management, and Vendor Oversight to explore strategies that improve clinical trial performance.
Featured Presentation
Quality by Design Begins Before Study Start-Up: Embedding Risk-Based Governance into CRO and Vendor Selection
Quality-by-Design (QbD) is often associated with protocol development and study execution. However, one of the most important opportunities to improve trial quality occurs much earlier, during the selection of CROs and critical vendors.
In this presentation, Vatché will discuss how sponsors can strengthen study oversight by incorporating risk-based governance, quality expectations, and operational performance criteria into partner selection from the outset.
Key discussion topics include:
- Applying Quality-by-Design (QbD) before study start-up
- Risk-based approaches to CRO and vendor selection
- Strengthening sponsor oversight and governance
- Moving beyond cost-driven outsourcing decisions
- Building collaborative partnerships that improve trial quality
Why Attend This Session?
Whether you are planning your first clinical trial or managing a global development portfolio, this session will provide practical strategies for improving operational performance by making better decisions before a study begins.
Meet with Vantage BioTrials
Planning an upcoming clinical program?
Meet with Vatché and his team to discuss how Vantage BioTrials helps biotechnology, pharmaceutical, and medical device sponsors strengthen clinical trial execution through:
- Clinical Trial Management
- Quality-by-Design (QbD)
- Risk-Based Quality Management (RBQM)
- Clinical Operations Leadership
- Vendor Oversight
- Inspection Readiness
- Regulatory Compliance
Why Vantage BioTrials?
Vantage BioTrials partners with sponsors to transform clinical development strategies into successful clinical programs through disciplined execution, proactive risk management, and collaborative operational leadership.
Our experienced team works as an extension of sponsor organizations, helping identify and mitigate risks early while maintaining the highest standards of patient safety, regulatory compliance, and data integrity.
Schedule a Meeting
If you will be attending the 10th Operational Excellence in Clinical Trials Summit, we invite you to connect with Vatché to discuss your upcoming clinical development objectives.